US FDA Preparing For Potential Bolus Of Complex Generic Applications

 
• By Derrick Gingery

Increasing number of product development meetings suggests that many complex generics remain in the development stages.

Wave building. Alamy
An increase in pre-submission meeting requests going forward could predict a complex generic application rush. • Source: Alamy

More from Generics

More from Biosimilars & Generics